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ABSTRACT
Irradiation can cause salivary gland hypofunction, with hyposalivation producing 
discomfort, health risks, and reducing function in daily life. Despite increasing translational 
research interest in radioprotection, there are no satisfactory treatments available. 
Keratinocyte growth factor-1 stimulates proliferation of salivary epithelial cells or salivary 
stem/progenitor cells. However, the exact mechanism of its radioprotection against 
radiation-induced salivary hypofunction is not fully elucidated. Our results reveal that 
the radioprotective effects of keratinocyte growth factor-1 involved alleviation of growth 
inhibition and anti-apoptotic cell death of human parotid epithelial cells. Furthermore, 
keratinocyte growth factor-1 protected human parotid epithelial cells through the 
phosphoinositide 3-kinase – protein kinase B (Akt) pathway and inhibition of p53-mediated 
apoptosis through activation of mouse double minute 2. Local delivery of keratinocyte 
growth factor-1 into the irradiated salivary glands could protect radiation-induced salivary 
cell damages, suppress p53-mediated apoptosis and prevent salivary hypofunction in vivo.  
This suggests that keratinocyte growth factor-1 is a promising candidate to prevent 
radiation-induced salivary hypofunction and raise rational development keratinocyte growth 
factor-1 local delivery system.
INTRODUCTION
Radiotherapy is the main treatment in patients with 
head and neck cancer. Due to the structural proximity and 
complexity in head and neck area, irradiation-induced 
salivary gland (SG) damage is common. Hyposalivation-
related complications such as xerostomia, halitosis, 
burning sensation, bizarre taste, swallowing difficulty and 
dental caries decrease the quality of life [1]. In spite of 
advances in SG-sparing radiation techniques, it remains 
challenging to prevent irradiation-induced salivary 
hypofunction. 
Our previous study found that mesenchymal stem 
cell-secreted bioactive factors provide radioprotection and 
tissue remodeling [2]. An increasing number of studies 
using bioactive factors for prevention or amelioration of 
irradiation-induced SG damage have been conducted [3–6]. 
Keratinocyte growth factor-1 (KGF-1, also known as FGF-7) 
stimulates the growth of epithelial cells and protects those 
cells from chemotherapy or radiotherapy-induced oral 
mucositis. Recombinant KGF (Palifermin) has been approved 
as a cytoprotective drug to reduce the symptoms of oral 
mucositis [7, 8]. KGF-1 also has potential for amelioration 
of irradiation-induced salivary hypofunction [5, 6]. 
KGF-1 is a member of FGF7/10/22 subfamilies 
and acts exclusively through a subset of FGF receptors, 
FGFR2IIIb [9]. KGF-1 is related to epithelial cell growth, 
differentiation, survival, and DNA repair [10]. Although 
KGF-1 effectively protects and regenerates damaged 
epithelial cells in the gastrointestinal mucosa, lung 
and oral mucosa [9–14], the exact mechanisms are not 
understood, particularly in terms of radioprotection on 
epithelial cells of SGs. 
In this study, we investigated the KGF-1 mechanism 
related to anti-apoptotic effect in vitro and determined 
whether the KGF-1 could prevent salivary hypofunction 
in vivo. Our results indicate for the first time that KGF-1 
can provide radioprotection to SG epithelial cells by 
reducing DNA damage and p53-mediated apoptosis 
following irradiation, in which phosphoinositide 3-kinase 
(PI3K)- protein kinase B (Akt)-p53 pathway mediates the 
radioprotective effect of KGF-1. 
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RESULTS
Irradiation response of human parotid epithelial 
cells in vitro 
We initially investigated irradiation response of 
human parotid epithelial cells (hPECs) in vitro to examine 
the mechanisms of KGF-1 on radioprotection of salivary 
epithelial cells. KGF-1 was administered immediately 
after irradiation. We assessed morphological changes, 
proliferation, and cytotoxicity of the monolayer cultured 
hPECs at one, two, and three days after irradiation at a 
dosage of 0, 15, and 20 Gy. Irradiation at a dosage of 
15 and 20 Gy induced morphological changes of hPECs 
from a cuboidal, cobblestone appearance to destroyed, 
fibroblastoid morphology (Figure 1A). Irradiation 
significantly decreased proliferation and increased 
cytotoxicity by LDH release in the hPECs in a time 
dependent manner (Figure 1B and 1C). HPECs with 20 Gy 
of irradiation lost significant proliferative capacity while 
increasing LDH release from one day post-irradiation, 
suggesting an irradiation dose-response relationship. 
KGF-1 at concentrations of 50, 100, and 200 ng/ml 
alleviated irradiation-induced growth inhibition and 
cytotoxic damage by irradiation at two days after 
irradiation (Figure 1D–1F). There was a more significant 
effect of 100 or 200 ng/ml of KGF-1 on irradiation-
induced changes in cell proliferation and viability in 
hPECs than 50 ng/ml of KGF-1 (Figure 1E and 1F). In 
addition, 100 ng/ml of KGF-1 successfully reduced 
irradiation-induced growth inhibition and cell death by 
live/dead staining (Figure 1G–1I). KGF-1 itself did not 
affect cell proliferation or cell death. Based on these 
observations, 100 ng/ml of KGF-1 was chosen for further 
experiments. 
To investigate the phenotypic markers expression, 
mRNA and protein expression of acinar markers; 
α-amylase (AMY1A) and AQP5 (AQP5), ductal markers; 
CK7 (KRT7) and CK18 (KRT18), intercellular adherence 
protein; E-cadherin (CDH1), and TJ protein; ZO-1 
(TJP1) were compared among the groups at two days 
after irradiation (Figure 2A and 2B). Irradiation reduced 
the salivary epithelial markers (α-amylase, AQP5, CK7, 
and CK18), ZO-1, and E-cadherin expression. KGF-1 
treatment enhanced all the salivary epithelial markers and 
increased the ZO-1 and E-cadherin expression. 
Radioprotective mechanisms of KGF-1
To understand the mechanism of irradiation-induced 
cell death, we performed an in vitro TUNEL assay, which 
revealed the presence of fragmented hPEC DNA. These 
findings are direct evidence of apoptotic cell death. 
Irradiation significantly increased DNA fragments and 
TUNEL-positive apoptotic cells and KGF-1 successfully 
reduced DNA fragments and TUNEL-positive apoptotic 
cells (Figure 3A). We investigated whether cell death 
was related to irradiation-induced DNA damage, and 
our results showed that DNA damage marker, γH2AX 
significantly decreased after KGF-1 treatment (Figure 3A). 
In addition, the radioprotective effect of KGF-1 against 
DNA damage and cell death was inhibited in the presence 
of FGFR2 inhibitor or PI3k inhibitor in the medium 
(Figure 3B–3C).
To analyze whether the radioprotective effect 
of KGF-1 is attributed to an anti-apoptotic effect, we 
examined the changes in apoptosis-associated proteins 
including p53, PUMA, Bax, cytochrome c, cleaved 
caspase-9 and -3, and Bcl-2. Irradiation increased the 
expression of pro-apoptotic proteins; p53, PUMA, Bax, 
cytochrome c, and cleaved caspase-9 and -3, whereas it 
decreased the expression of anti-apoptotic protein Bcl-2 
(Figure 3D). Importantly, KGF-1 treatment significantly 
inhibited the irradiation-induced induction in expression 
of pro-apoptotic proteins and increased the expression of 
anti-apoptotic protein. In the presence of FGFR2 inhibitor 
to block endogenous KGF signaling, irradiation-induced 
apoptosis in hPECs was still observed, suggesting an 
anti-apoptotic effect of exogenous KGF-1. In sum, 
the protective effect of KGF-1 on irradiation-induced 
apoptosis in hPECs is associated with regulation of 
p53-mediated apoptosis pathway (Figure 3D). 
To determine the signaling pathway, we next 
explored the expression of FGFR2 and its downstream 
signal transduction pathway. Given the role of PI3K-Akt 
pathway of growth factor signaling, we examined 
activation of PI3K, its downstream target, Akt, and 
an important p53 suppressor, murine double minute 2 
(MDM2). Irradiation reduced the expression of PI3K-
Akt-MDM2 axis (Figure 3E). Phosphorylations of 
PI3K, Akt, and MDM2 were enhanced in response 
with KGF-1 pretreatment. These results suggest that 
KGF-1 induces PI3K and Akt activation and subsequent 
phosphorylation of MDM2 inhibits irradiation-induced 
p53 activation. In the presence of PI3K inhibitor, the 
loss of Akt phosphorylation confirmed the efficacy of the 
inhibitor, and inhibition of MDM2 phosphorylation by 
PI3K inhibitor suggested that down-regulation of the anti-
apoptotic pathway antagonized p53 and its downstream 
pro-apoptotic proteins (Figure 3F–3G). Furthermore, both 
inhibitors blocked the promotion of proliferative capacity 
and inhibition of apoptosis by KGF-1 (Figure 3H). These 
results provide support for the protection of KGF-1 by 
blocking apoptotic signaling pathway that is induced by 
known PI3K-Akt-MDM2 axis (Figure 3I).
Morphological improvement, cytoprotection and 
anti-apoptosis following irradiation by KGF-1 
treatment
We determined that rat salivary epithelial cells 
in vivo demonstrated immunoreactivity to FGFR2 (data not 
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shown). Next, we performed an in vivo experiment testing 
whether local administration of KGF-1 could ameliorate 
irradiation-induced salivary hypofunction. External 
appearance and dissected SGs in each group were observed 
at 16 weeks after irradiation. Neck irradiation resulted in 
loss of hair around the neck and decreased glandular size, 
but KGF-1-treated rats showed less hair loss and larger 
glandular size than the irradiation group. Body weight 
and dissected glandular weight were measured at two 
and 16 weeks after irradiation (Figure 4A and 4B). Body 
weight and glandular weight were significantly lower in 
the irradiation group than the control group at two and 
16 weeks after irradiation. However, KGF-1 treatment 
led to significantly increased body and glandular weight 
compared to the irradiation group at 16 weeks after 
treatment. 
Histological evaluations of the micro-morphological 
changes were performed and the densities of mucin were 
measured by PAS staining followed by examination 
by a blinded researcher using a software program to 
calculate the pixels of purple stained areas at 16 weeks 
after irradiation. The salivary acinoductal structure was 
destroyed and reduced after irradiation, but maintained 
in the KGF-1 group (Figure 4C). Morphometric analysis 
of PAS staining showed that mucin production decreased 
significantly after irradiation, but increased significantly 
Figure 1: Morphological changes, cell proliferation and viability of hPECs after irradiation. (A) Irradiation induced 
morphological changes of hPEC in a time- and dose-dependent manner. Scale bars represent 100 μm. (B) Proliferation of hPEC after 
irradiation was examined. (C) Cytotoxicity of hPEC after irradiation was examined. Data are presented as the means ± SEM (n = 5). 
Two-way ANOVA, Bonferroni›s post hoc test. *, compared to 0Gy in each group; #, compared to 15 Gy in each group, $, compared to 
15 and 20 Gy in 2 days. ***P <0.001, ###P < 0.001, $$$P < 0.001. (D) Effect of dose dependent-KGF-1 on irradiation-induced changes 
in cell proliferation and viability in hPEC. Scale bars represent 100 μm. (E) Proliferation of hPEC after IR+KGF-1 was examined. 
(F) Cytotoxicity of hPEC after IR+KGF-1 was examined (n = 5). One-way ANOVA, Tukey’s post hoc test. *, compared to IR; #, compared 
to IR+KGF-1 (50 ng/ml). *P < 0.05, **P < 0.01, ***P < 0.001, #P < 0.05, ##P < 0.01, ###P < 0.001. (G) Effect of KGF-1 on irradiation-
induced changes in cell proliferation and viability in hPEC. Scale bars represent 100 and 200 μm. (H) Proliferation of hPEC after IR+KGF-1 
was examined. (I) Cytotoxicity of hPEC after IR+KGF-1 was examined (n = 5). One-way ANOVA, Tukey’s pot hoc test. *, compared to 
CON; #, compared to IR; $, compared to IR+KGF-1. ***P < 0.001, ###P < 0.001, $$P < 0.01, $$$P < 0.001. 
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in the KGF-1 group relative to the irradiation group 
(Figure 4C and 4D). MTC staining showed irradiation-
induced fibrotic changes in peri-acinoductal area but less 
in the KGF-1 group (Figure 4C and 4D). 
We next investigated the cellular effects of KGF-1 
on salivary epithelial, endothelial, myoepithelial, and 
ductal cells (Figure 4E). Immunohistochemical staining 
revealed that expression of AQP5 (a marker of salivary 
epithelial cells), CK18 (ductal cells) CD31 (endothelial 
cells), and α-SMA (myoepithelial cells) was significantly 
lower in the irradiation group than the control group 
(Figure 4E and 4F). Treatment of the KGF-1 increased the 
Figure 2: Effect of KGF-1 on salivary mRNA and protein expression. (A) Irradiation significantly decreases the salivary acinar 
markers (α-amylase; AMY1A and AQP5; AQP5), TJ protein (ZO-1; TJP1), adherence protein (E-cadherin; CDH1), and ductal markers 
(CK7; KRT7 and CK18; KRT18) in hPEC that is increased by treatment with KGF-1 (100 ng/ml) (n = 9). One-way ANOVA, Tukey’s post 
hoc test. *, compared to CON; #, compared to IR. ***P < 0.001, ###P < 0.001. (B) The protein translation of the same markers in Figure 2A 
was examined by Western blot, and the expression levels relative to β-actin were calculated (n = 3). One-way ANOVA, Tukey’s post hoc 
test. *, compared to CON; #, compared to IR. **P < 0.01, ***P < 0.001, #P < 0.05, ##P < 0.01, ###P < 0.001.
Oncotarget13500www.impactjournals.com/oncotarget
staining density of these cells relative to the irradiation 
group, suggesting KGF-1 could preserve myoepithelial 
and endothelial cells as well as salivary epithelial cells 
against irradiation-induced cell depletion. 
Next, we performed an in vivo experiment testing 
whether local delivery of KGF-1 could prevent irradiation-
induced salivary hypofunction. Local irradiation at 15 Gy 
to the neck induced apoptosis in SGs, whereupon TUNEL 
positive apoptotic cells were markedly increased at 
24 hours after irradiation (Figure 4G). Apoptotic cell 
death, however, was reduced by treatment with KGF-1 
before and immediately after irradiation. Quantification 
of TUNEL positive cells revealed that a significant 
increase in apoptosis was observed after irradiation, but 
this decreased significantly following KGF-1 treatment 
relative to the irradiation (vehicle PBS treated) group 
(Figure 4H). KGF-1 alone without irradiation did 
not increase cell death. We  examined the changes in 
apoptosis-associated proteins in vivo (Figure 4I and 4J). 
Similar to in vitro findings, irradiation increased the 
Figure 3: Effect of KGF-1 on apoptosis and apoptosis-related protein expression. (A) KGF-1 effect of TUNEL positive 
cells and DNA damages in hPECs. (B) Comparison of the percentages of TUNEL-positive apoptotic cells among groups. (C) Comparison 
of the percentages of DNA damages among groups. Data are presented as the mean number of apoptotic cells per field ± SEM (n = 3). 
One-way ANOVA, Tukey’s post hoc test. *, compared to CON; #, compared to IR; $, compared to IR+KGF-1. ***P < 0.001, ###P < 0.001, 
###P < 0.001. (D–G) Effect of FGFR2 and PI3k inhibitor on irradiation-induced FGFR2-PI3k pathway and apoptosis. FGFR2 and PI3k 
inhibitor induces an increase of FGFR2-PI3k-related protein and pro-apoptotic protein in hPECs. (H) Comparison of the proliferation 
capacities among groups. (n = 5). One-way ANOVA, Tukey’s post hoc test. *, compared to CON; #, compared to IR, $, compared to 
IR+ KGF-1. ***P < 0.001, ###P < 0.001, $$$P < 0.001. (I) Proved signaling pathway of KGF-1 to block the apoptosis and DNA damage of 
hPECs after irradiation.
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Figure 4: Macro- or micro-morphological evaluation, cytoprotective effect and anti-apoptosis of KGF-1 treatment. 
(A and B) Body weight and dissected glandular weight were measured at two and 16 weeks after irradiation. Two-way ANOVA, Bonferroni’s 
post hoc test. *, compared to CON in each group; #, compared to IR+PBS in each group. . *P <0.05, **P <0.01, ***P <0.001, #P < 0.05, 
##P < 0.01. (C) Representative histological pictures of H-E, PAS and MTC staining from three groups at 16 weeks post-irradiation are 
presented. Scale bars represent 50 μm. (D) Densities upon PAS (upper) staining were measured using a software program to calculate pixels 
of purple stained mucin-containing areas. MTC (lower) staining showed the IR+KGF-1 group exhibited less periductal and perivascular 
fibrosis than the IR group. One-way ANOVA, Tukey’s post hoc test. *, compared to CON; #, compared to IR. ***P < 0.001, ###P < 0.001. 
(E) Representative images of salivary epithelial (AQP5), endothelial (CD31), myoepithelial (α-SMA), and ductal cells (CK18) in the SG in 
the three experimental groups. Scale bars represent 50 μm. (F) Each staining area was measured in pixels using a software program. Data 
are presented as the mean area (%) ± SEM. One-way ANOVA, Tukey’s post hoc test. *, compared to CON; #, compared to IR. *P < 0.05 
**P < 0.01 ***P < 0.001, #P < 0.05, ##P < 0.01. two weeks (n = 3 in all groups), 16 weeks CON group (n = 3), IR+PBS group (n = 3), 
IR+KGF-1 group (n = 2). Five random sections from each rat were evaluated by a blinded researcher. The number of slides examined from 
each experimental group ranged from 18 to 21. (G) Representative images of an in vivo TUNEL assay from three experimental groups at 
two weeks post-irradiation. Scale bars represent 50 μm. (H) The number of TUNEL-positive apoptotic cells was determined by a blinded 
researcher. Data are presented as the mean number of apoptotic cells per field ± SEM. One-way ANOVA, Tukey’s post hoc test. *, compared 
to CON; #, compared to IR. ***P < 0.001, ###P < 0.001. (n = 2 mice in all groups. Five random sections in each experimental group were 
examined.) (I) Representative images of apoptotic cascades as determined by Western blotting. (J) Comparison of p53, PUMA, BAX, 
cytochrome C, cleaved caspase-3, cleaved caspase-9 and Bcl-2 expression (results are presented as the mean ± SEM). One-way ANOVA, 
Tukey’s post hoc multiple comparisons test. *, compared to CON; #, compared to IR; $, compared to IR+KGF-1. ***P < 0.001, ##P < 0.01, 
###P < 0.001, $P < 0.05, $$P < 0.01. (n = 2 mice in all groups).
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expression of pro-apoptotic proteins; p53, PUMA, Bax, 
cytochrome c, and cleaved caspase-9 and -3, whereas it 
decreased the expression of anti-apoptotic protein Bcl-2. 
KGF-1 treatment significantly inhibited the irradiation-
induced induction in expression of pro-apoptotic proteins 
and increased the expression of anti-apoptotic protein. 
These findings suggest that the radioprotective effect of 
KGF-1 is associated with regulation of p53-mediated 
apoptosis pathway in vivo.
Recovery of irradiation-induced salivary 
hypofunction
The amount of salivation and lag time were measured 
pre-radiation and two and 16 weeks post-radiation. 
The changes in SFR and lag time after irradiation were 
calculated by the post- radiation to pre-radiation ratio. 
Irradiation significantly decreased the ratio of SFR at 
16 weeks and increased the ratio of the lag time at two 
and 16 weeks after irradiation (Figure 5A and 5B). KGF-1 
treatment significantly improved the ratio of SFR and the 
lag time at 16 weeks after irradiation. We performed western 
blotting of saliva collected at 16 weeks post-radiation to 
examine the salivary amylase and EGF protein expression 
level (Figure 5C). The expression levels of salivary amylase 
and EGF were higher after KGF-1 treatment relative to 
the irradiation group. The average activity of salivary 
amylase was significantly reduced in the irradiation group 
(Figure 5D), and it was significantly improved in the KGF-1 
group. EGF contents in saliva at each time point were also 
confirmed by ELISA. The average concentration was 
significantly lower in the irradiation group than the control 
group (Figure 5E), and significantly increased in the KGF-1 
group relative to the irradiation group at 16 weeks after 
treatment.
DISCUSSION
In this study, we investigated the KGF-1 mechanism 
related to the anti-apoptotic effect in vitro and protective 
effects of local administration of KGF-1 on SG function 
following irradiation in vivo. With KGF-1 treatment, 
we verified the radioprotective mechanism of KGF-1 
by protection against DNA damage and p53-mediated 
apoptosis through PI3K-Akt pathway after irradiation 
using human SG epithelial cell culture in vitro. Salivary 
function recovered within 16 weeks after irradiation 
and these findings are supported by an earlier study that 
delivered KGF-1 gene to submaxillary glands transductally 
in mice [5]. 
Figure 5: Effect of salivary function by KGF-1 treatment. (A) Salivary flow rate (SFR) was calculated at pre-irradiation and 2 
and 16 weeks post-irradiation. The changes in SFR after irradiation were expressed by the ratio of post-irradiation SFR to pre-irradiation 
SFR (Mean ± SEM). (B) Time to salivation (lag time, LT) was measured and the ratios of post-irradiation LT to pre-irradiation LT were 
presented. Data are presented as the mean ± SEM. (A, B and E) Two-way ANOVA, Bonferroni’s post hoc test. *, compared to CON in 
each group; #, compared to IR+PBS in each group. . *P < 0.05, **P < 0.01, #P < 0.05. (C) Western blotting of amylase and EGF in saliva at 
16 weeks post-irradiation. (D) The salivary amylase activity was examined by the Assay Kit and fold changes in activity level are presented. 
(E) EGF contents were measured at each time point and the average contents are presented. Data are presented as the mean ± SEM. 
One-way ANOVA, Tukey’s post hoc test. *, compared to CON; #, compared to IR. *P < 0.05, ***P < 0.001, ##P < 0.01. 2 weeks (n = 3 in 
all groups), 16 weeks CON group (n = 3), IR+PBS group (n = 3), IR+KGF-1 group (n = 2).
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The exact mechanism of SG dysfunction induced 
by irradiation remains unclear. Irradiation causes DNA 
damage and generates reactive oxygen species, an 
important cause of apoptotic cell death in target tissues. 
Reactive oxygen species lead to apoptosis and to the 
up-regulation of inflammatory cytokines. The latter can 
produce further tissue damage, amplifying signaling 
cascades and the entire injury process [15]. One of the 
most consistent phenomena in SG response to irradiation is 
the loss of cellular components in our study. These findings 
imply that a continued apoptotic response contributes 
to these observations. Avila et al. suggested that the 
apoptotic response after irradiation is mediated by p53 
and is directly associated with salivary dysfunction [16]. 
p53 induces apoptosis by transcriptional regulation of 
target genes, and involves mitochondrial cytochrome c 
release and caspase9 and -3 cascades [17]. A number of 
p53-regulated genes have been identified, and some of 
these represent potential downstream mediators of p53- 
dependent apoptosis including Bax and PUMA [18, 19]. 
The Bax protein accumulates in mitochondria in response 
to death signals [18]. PUMA localizes to the mitochondria 
and interacts with Bax. PUMA interaction with Bax 
rapidly induces apoptosis through cytochrome c release 
and activation of caspase-3 and -9 [19]. Irradiation 
increases expression of pro-apoptotic proteins and 
decreases expression of anti-apoptotic protein. KGF-1 
treatment significantly decreases the irradiation-induced 
expression of pro-apoptotic proteins and increases the 
expression of anti-apoptotic protein. 
PI3K/Akt pathway is important in cell survival and 
proliferation in cells [20, 21]. To addressing the role of 
KGF-1 to block the apoptosis in the model of hPECs, we 
focused on the PI3K/Akt signaling axis, a pathway with 
protective effects that inhibit cell apoptosis. We postulated 
that KGF-1 could induce PI3K, Akt, and MDM2 
phosphorylation in hPECs. Phosphorylations of PI3K-
Akt-MDM2 axis were enhanced in response with KGF-1 
pretreatment. These results support our hypothesis that 
KGF-1 preserves hPECs viability by inhibiting apoptosis, 
probably by mediating the PI3K-Akt-MDM2 pathway. 
As a critical regulator of PI3K-mediated cell survival, 
activation of Akt signaling is sufficient to block cell death 
induced by apoptotic stimuli. The mechanisms underlying 
the cytoprotective effects of KGF-1 in epithelial cells 
are mediated via PI3K–Akt signaling [22, 23]. These 
findings are reproduced in our study that KGF-1 treatment 
reduced the extent of irradiation-induced DNA damage 
and apoptotic cell death in salivary epithelial cells 
via activation of the receptor tyrosine kinase (RTK), 
FGFR2IIIb and PI3K-Akt signaling transduction pathway. 
PI3K is a vital regulatory protein responsible for cell 
growth, proliferation, differentiation, motility, and survival 
and these functions are related to the ability to activate 
protein kinase B (Akt). Akt mediates anti-apoptotic 
action through phosphorylation of multiple downstream 
targets including MDM2, a p53 interacting protein that 
downregulates p53 transcriptional activity [24]. 
Salivary parenchymal cells have FGFR2 receptors 
that are required for KGF-1 signaling [6]. We first 
examined sections of SGs to determine whether they 
expressed FGFR2 and rat salivary parenchymal cells 
showed FGFR2, and it was distributed to ductal area. 
KGF-1 has the potential to protect many types of cells 
against irradiation [6, 10, 14, 25, 26]. Our results showed 
that the KGF-1 administered to SGs can prevent irradiation 
damage in acinar, ductal, endothelial and salivary stem/
progenitor cells. Lombaert IM et al. demonstrated that 
expansion of salivary stem/progenitor cells was achieved 
by subcutaneous administration of KGF-1, resulting in the 
preservation of saliva secretion after irradiation in mice [5]. 
Transductal KGF-1 gene delivery to submaxillary glands 
successfully prevents salivary hypofunction by increasing 
proliferation of salivary parenchymal and endothelial 
cells [6]. Salivary microvascular endothelial cells might 
be early and sensitive targets of irradiation in both murine 
and porcine SGs [27, 28]. 
 In this study, KGF-1 was delivered to SGs through 
local injection because of concern that systemic delivery 
of KGF-1 could produce a malignancy [29, 30]. Intraductal 
delivery of adenoviral vectors to rodent SGs has been 
shown to be safe [31–34]. However, intravenous delivery 
does not alter tumor response or patient survival [7]. Using 
murine xenograft models for head and neck and colorectal 
carcinoma, KGF-1 given subcutaneously had no effect 
on either tumor growth or antitumor chemotherapeutic 
activity [8]. To begin to address these concerns, this study 
examined the protective efficacy of KGF-1 when locally 
administered to irradiate SGs in vivo. We injected KGF-1 
twice (1 hour before and immediately after irradiation) 
so that KGF-1 locally injected into SG could act as a 
mitigator of early radiation damage.
In summary, the present study shows that locally 
administrated KGF-1 into the irradiated SGs effectively 
protects SG subtype cells, preventing hypofunction of 
salivation in vivo. The PI3K-Akt- pathway mediates the 
anti-apoptotic effect of KGF-1 in salivary epithelial cells, 
and leads to activation of Mdm2 and blockade of the 
p53-mediated apoptotic pathway. Our results here clearly 
show that new strategies for development and design of 
novel effective therapeutic drugs based on the activation 
of KGF-1 signaling pathways are needed for treatment of 
patients with irradiated SG damage. Thus, KGF-1 may be 
beneficial to prevent irradiation-induced SG hypofunction 
in patients being treated for head and neck cancers.
MATERIALS AND METHODS
Human salivary gland epithelial cells culture
We obtained hPECs from a patient who underwent 
parotidectomy due to benign parotid tumor, as described 
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in our previous study [35]. The specimen was collected 
with informed consent and institutional review board 
approval. A small portion of a non-tumor bearing 
gland was resected and washed thrice with cold 1×PBS 
containing 1% antibiotics. The tissue was finely chopped 
and enzymatically digested with 0.25% collagenase type 
B (2.5 mg/mL) and DNase I (1 mg/mL) with gentle 
shaking at 37°C for 30 minutes. The cell suspension 
was subsequently filtered through a 70 μm cell strainer, 
then centrifuged at 1500 rpm for five minutes, after 
which it was plated on a culture dish and cultured with 
Keratinocyte-Serum Free Medium (KSFM; Gibco, Grand 
Island, NY, USA) containing epidermal growth factor 
(EGF, 5 ng/ml), calcium chloride (CaCl2, 0.09 mM) and 
1% antibiotics. 
In vitro irradiation and cell morphology
For irradiation experiments, the hPECs at passage 
2–3 were seeded at 2 × 104 cells/well, cultured at 37°C 
for three days on 6-well plates, and irradiated with 
0, 10, and 20 Gy using a 4 MV X-ray from a linear 
accelerator (Mevatron MD, Siemens Medical Laboratories 
Inc., Germany). 100 ng/ml KGF-1 (R&D Systems, 
Minneapolis, MN, USA) was administered immediately 
after irradiation, cell morphology was analyzed under an 
inverted phase-contrast microscope (Olympus FV1000, 
Olympus, Tokyo, Japan), and images were obtained 
using a digital camera at one, two, and three days after 
irradiation.
Cell proliferation, cytotoxicity, and viability 
To investigate the cell proliferation of hPECs, an MTS 
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) uptake assay was used. 
HPECs were seeded at 1 × 104 cells/well, cultured at 37°C 
for three days. The cultured cells were randomly divided into 
three groups: 1) Normal control group without irradiation 
and KGF1 treatment (CON), 2) irradiation without KGF-
1-treatment (IR), 3) Irradiation with KGF-1-treatment 
(IR+KGF-1). The IR and IR+KGF-1 groups were irradiated 
with 15 or 20 Gy using 4 MV X-ray from a linear accelerator 
(Mevatron MD, Siemens Medical Laboratories Inc., 
Germany). KGF-1 (50 ng/ml or 100 ng/ml or 200 ng/ml, 
R&D Systems, Minneapolis, USA) was applied in KGF-1 
added groups after irradiation. After addition of 20 μl MTS 
reagent and incubation at 37°C for four hours, proliferation of 
hPECs was investigated by reading the absorbance at 490 nm 
using a 96-well plate reader (Dynex Revelation, Dynex Ltd., 
Billingshurst, UK). At 1, 2, 3 days after irradiation, 100 μl 
of supernatant per well was harvested and transferred into a 
new 96-well, flat-bottom plate. LDH substrate (100 μl) was 
added to each well and incubated for 30 minutes at room 
temperature protected from light. The absorbance of the 
samples was measured at 490 nm with an ELISA reader. 
For assessment of proliferation and cytotoxicity following 
irradiation, at least three independent experiments were 
performed.
To assess the cell viability, a LIVE/DEAD assay 
kit (Invitrogen, CA, USA) was utilized according to the 
manufacturer’s instructions. HPECs were seeded in 6-well 
plates at a density of 2 × 105 cells per well and cultured for up 
to three days. Cells were washed with 1×PBS, detached using 
0.5% Trypsin-EDTA, neutralized with cell culture media, 
and collected in 50 ml tubes. Next, cells were centrifuged 
at 1500 rpm for five minutes, the supernatant was discarded, 
and pellets were resuspended in trypan blue dye in media for 
one minute before counting using a hemocytometer.
Evaluation of apoptosis, DNA damage 
The cultured cells were randomly divided into five 
groups: 1) Normal control group without irradiation and 
KGF-1 treatment (CON), 2) Irradiation without KGF-1-
treatment (IR), 3) Irradiation with KGF-1-treatment (IR+ 
KGF-1), 4) FGFR2 inhibitor added before irradiation and 
KGF-1 treatment after irradiation (IR+FGFR2 inhibitor), 
5) PI3k inhibitor added before irradiation and KGF-1 
treatment after irradiation (IR+PI3k inhibitor). For 
immunofluorescence staining, cells were washed and 
fixed in 4% paraformaldehyde for 20 minutes at room 
temperature, then permeabilized with 0.4% Triton X-100 
in 1×PBS for 10 minutes at room temperature. After 
washing with 1×PBS, cells were treated with 1% BSA 
in 1×PBS for one hour before incubation with primary 
antibodies specific for anti-γ-H2AX (Abcam, Cambridge, 
UK) in 1% BSA overnight at 4°C. The cells were washed 
in PBS before incubation with a goat anti-rabbit IgG-
Alexa-488-conjugated secondary antibody (Invitrogen, 
Camarillo, CA, USA) for six hours at room temperature 
in the dark. The nucleus was counterstained with 
4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI; 
Vector Labs), after which the cells were viewed using a 
confocal laser scanning microscope (Olympus FV1000, 
Olympus, Tokyo, Japan).
Effects of the FGFR2 inhibitor, LY2874455 (2 nΜ, 
Sellekchem, Boston, MA, USA), PI3k inhibitor, BKM120 
(100 nΜ, Sellekchem, Boston, MA, USA) on the action 
of KGF-1 in irradiation-induced changes of hPECs were 
investigated. The hPECs at passage 2–3 were seeded at 
2 × 104 cells/well, cultured at 37°C for three days on 6-well 
plates, and irradiated with 0, 10, and 20 Gy using a 4 MV 
X-ray from a linear accelerator (Mevatron MD, Siemens 
Medical Laboratories Inc., Germany) before treatment with 
FGFR2 inhibitor (2 nM) and PI3k inhibitor (100 nM).
Evaluation of salivary phenotypic gene 
expression
The levels of transcripts were determined by 
real-time PCR (RT-PCR) on the ABI PRISM sequence 
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detection system using SYBR Green I as a double-stranded 
DNA-specific dye according to the manufacturer’s 
instructions (Applied Biosystems, Foster City, CA, USA). 
The PCR reaction was carried out using 1 μM cDNA, 
10 μM SYBR Green PCR master mix (Roche Diagnostics, 
Laval, Quebec, Canada), 10 pM sense and antisense 
primers specific for α-amylase (AMY1A), AQP5 (AQP5), 
E-cadherin (CDH1), ZO-1 (TJP1), CK7 (KRT7) and 
CK18 (KRT18) in a reaction mixture with a final volume 
of 20 µL (Table 1). The amount of real-time PCR products 
was normalized with the house-keeping gene, β-actin.
Western blotting
For western blot analysis, samples were isolated 
from the lysate (30 μg), mixed in reducing buffer, boiled, 
resolved on sodium dodecyl sulfate polyacrylamide 
gel electrophoresis, and transferred to a polyvinylidene 
difluoride membrane by blotting. The blot was incubated 
overnight at 4°C in a blocking solution with primary 
antibodies to the following antigens: α-amylase, AQP5, 
ZO-1, CK7, CK18, FGF7, FGFR2, p53 upregulated 
modulator of apoptosis (PUMA) and β-actin (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA); E-cadherin (BD 
Pharmingen, San Diego, CA, USA); p53, Bax (Abcam, 
England); Bcl-2, Cytochrome C, Cleaved caspase-9 and 
Cleaved caspase-3, protein kinase B (PI3K), p-PI3K, 
Akt, p-Akt and murine double minute 2 (MDM2), 
p-MDM2 (Cell signaling, Danvers, MA, USA). After 
washing the blots with 0.1% Tween 20 in 1×PBS, they 
were incubated with horseradish peroxidase-conjugated 
secondary antibodies corresponding to each primary 
antibody, after which they were subjected to enhanced 
chemiluminescence detection (GE Healthcare Life 
Science, USA).
Animal experiments
This study was approved by the Animal Ethics 
Committee of Inha University Hospital. Animals were 
cared for in accordance with established institutional 
guidelines. Female SD rat (n = 24) weighing 280–350 g 
were used for the experiments. (Orient Bio, Gyeonggi-Do, 
Korea) The animals were kept under clean, conventional 
conditions. They were given access to standard laboratory 
food and sterilized water ad libitum. Rats were anesthetized 
with xylazine (10 mg/kg, i.p) and ketamine (100 mg/kg i.p) 
and fixed in a plane board. To cause irradiation-induced SG 
hypofunction, irradiation was carried out with 4 MV X-ray 
emitted from a linear accelerator (Mevatron MD, Siemens 
Medical Laboratories Inc., Germany) with a single dose 
of 15 Gy at a focus-to-skin distance of 100 cm. Rats were 
irradiated in the head and neck field with the body shielded 
from irradiation. 
KGF-1 was dissolved in PBS containing 0.1% 
BSA (100 µg KGF-1/ 1 ml PBS). A 5-mm incision to 
the left neck of the rats was made to expose ipsilateral 
submaxillary gland. KGF-1 (20 µl) or PBS solution 
(20 µl) was injected twice; 1 hour before irradiation and 
immediately after irradiation directly to the submaxillary 
glands using a syringe with a 21-gauge needle. After 
injections, the neck wound was sutured and sterilized. 
Vehicle (PBS)-treated rats were served as an irradiation 
control group. KGF-1-injected without irradiation group 
was included to determine its mitogenic effect.  
TUNEL assay
Apoptotic cells dissected glands at 24 hours 
after treatment were visualized using the Apoptag Plus 
Fluorescein In Situ Apoptosis Detection kit (Millipore, 
Bedford, MA, USA), and two blind examiners 
independently counted the absolute number of apoptotic 
cells in three random fields per tissue section under 400 × 
magnification. At least three random tissue sections per 
gland were chosen for each slide. 
For in vitro TdT-mediated dUTP nick-end labeling 
(TUNEL) staining, cells were washed and fixed in 4% 
phosphate-buffered paraformaldehyde for 25 minutes at 
20°C. After washing thrice with PBS, cells were stained 
using the In Situ Cell Death Detection Kit (Roche 
Diagnostics, Laval, Quebec, Canada) according to the 
manufacturer’s protocol. The nucleus was counterstained 
with DAPI, and the cells were visualized under the 
Axiovert 200 fluorescence microscope with 10 × 10 and 
20 × 10 NA objectives equipped with AxioCam HRC 
digital camera.
Morphological, histological, and 
immunohistochemical evaluation 
Body weights were measured at two and 16 weeks 
after irradiation followed by saliva collection and humane 
euthanasia. The submaxillary glands of the mice were 
harvested and the surrounding fat and connective tissues 
were removed. The glandular weights were measured 
and submaxillary glands were immediately placed in 4% 
paraformaldehyde at room temperature.
To evaluate the functionality of SG components, 
tissues were processed, embedded in paraffin, sectioned 
at 4 µm, and stained with hematoxylin-eosin (H&E), 
Masson›s Trichrome (MT) and Periodic Acid Schiff 
(PAS). The sections were washed in phosphate buffered 
saline (PBS) and pre-incubated for one hour in a blocking 
solution containing 5% normal goat serum in PBS. After 
a brief PBS wash, primary antibodies for aquaporin 
(AQP)-5 (Alomone labs, Jerusalem, Israel), cytokeratin 
(CK)-18 (Santa Cruz Biotechnology, Texas, USA), 
α-SMA and CD31 (Abcam, Cambridge, UK) diluted in 
blocking solution were applied. Sections were incubated 
overnight at 4°C, in secondary antisera (Invitrogen, 
Camarillo, CA, USA) for 90 minutes at room temperature, 
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and treated with avidin–biotin–peroxidase solution. The 
peroxidase label was visualized using diaminobenzidine 
as the chromogen (Vector Laboratories, Burlingame, CA, 
USA). Sections were washed, allowed to air dry, cover 
slipped, and processed for observation under a confocal 
microscope (IX81, Olympus, Center Valley, PA, USA). 
Three sections were made for each gland, three random 
fields per section of gland were checked by two blind 
examiners, and positive cell numbers or stained areas were 
measured using MetaMorph software (Molecular Devices 
Corporation, Sunnyvale, CA, USA).  
Salivary function evaluation
Salivary secretory function was determined by 
measuring salivary flow rate (SFR) and lag time of 
salivation at two and 16 weeks after irradiation. Saliva 
was collected using a micropipette for 10 minutes after 
stimulation by intraperitoneal injection of pilocarpine 
(2 mg/kg) when rat salivated in the floor of mouth. 
Collected saliva was placed in pre-weighed 1.5 ml micro-
centrifuge tubes, and SFR (µl/ml) was calculated as the 
total saliva weight (mg) divided by the collection time 
(minutes) (saliva has a specific gravity of 1 mg/ml). The 
lag time of salivation was determined as the time from 
stimulation to the beginning of saliva secretion. To reduce 
the effects of diurnal variation, saliva was collected 
consistently at 2:00 p.m.
Amylase and EGF contents in saliva
Saliva samples obtained at 16 weeks after irradiation 
were centrifuged at 6000 rpm for 15 minutes. Total 
supernatant protein concentrations were determined 
by bicinchoninic acid (BCA) assay (Pierce, Rockford, 
IL, USA), after which 1 µg of total saliva protein was 
separated on SDS-PAGE and transferred to an Immobilon 
nitrocellulose membrane (Millipore, Billerica, MA, USA). 
Next, the membrane was blocked with 5% skim milk/TBS 
for one hour at room temperature, then rinsed with wash 
buffer and incubated with mouse anti-amylase antibody 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a 
1:5000 dilution. Following overnight incubation with 
shaking at 4°C, the membranes were rinsed with wash 
buffer thrice for five minutes each. This was followed 
by incubation with a 1:5000 dilution of anti-mouse 
IgG horseradish peroxidase conjugate (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) for one hour 
at 37°C. Finally, samples were rinsed with wash buffer 
as above, after which detection was conducted using 
enhanced chemiluminescence (ECL) western detection 
reagents (Elpisbio, Daejeon, Korea). The bands of interest 
were detected using a luminescent image analyzer (4000 r, 
 Kodak, Rochester, NY, USA), and the results were 
quantified using a software program (Kodak).
In addition, amylase activity of secreted saliva 
was determined using a salivary α-amylase assay kit 
(Salimetrics LLC, State College, PA, USA) with 2-chloro-
p-nitrophenol linked with maltotriose as the chromogenic 
substrate according to the manufacturer’s instructions. 
The amount of α -amylase activity present in the sample 
is directly proportional to the increase in absorbance at 
405 nm observed using a standard laboratory plate reader.
Saliva EGF was measured by enzyme-linked 
immunosorbent assay (ELISA) using a commercial kit 
(Quantikine; R&D Systems, Minneapolis, MN, USA) 
according to the manufacturer’s instructions. The kit uses 
a sandwich ELISA that recognizes mouse EGF and has 
no detectable cross reactivity with other cytokines. Each 
sample from each group collected at different time points 
Table 1: Primers used for RT-PCR
Gene and symbol Primer sequences (5′–3′)
α-Amylase (AMY1A)
F AAT TGA TCT GGG TGG TGA GC
R CTT ATT TGG CGC CAT CGA TG
Aquaporin 5 (AQP5)
F ACT GGG TTT TCT GGG TAG GG
R GTG GTC AGC TCC ATG GTC TT
E-Cadherin (CDH1)
F CGC ATT GCC ACA TAC ACT CT
R TTG GCT GAG GAT GGT GTA AG
ZO-1 (TJP1)
F TTT GGC CGA GGG ATA GAA GT
R TAT TGC CAT CTC TTG CTG CC
CK7 (KRT7)
F CAG GAT GTG GTG GAG GAC
R AAC TTG GCA CGC TGG TTC T
CK18 (KRT18)
F GGA GGC TGG AGA GCA AAA TC
R AGT CAT CAG CAG CAA GAC GG
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was assayed in duplicate and the plate was read at 450 nm. 
The EGF concentration of the samples was determined by 
reading the optical density of the sample against the values 
of the standard curve.
Statistical analysis 
Statistical analysis was conducted using the Graph 
Pad Prism 5 package (GraphPad Software Inc., La Jolla, 
CA, USA). The Mann-Whitney test was used to assess 
differences between groups. One way ANOVA followed 
by Tukey’s post hoc test and two-way ANOVA followed 
by the Bonferroni post hoc test were used to compare 
values among groups. Linear regression was applied 
to evaluate the association between parameters. Null 
hypotheses of no difference were rejected if p-values were 
less than .05.
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